Clinical Trials Directory

Trials / Completed

CompletedNCT05639283

Primary Obstructive Megaureter Management in Eastern Interregional Area

Primary Obstructive Megaureter Management in Eastern Interregional Area : Current Status and Perspectives

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
1 Year – 17 Years
Healthy volunteers
Not accepted

Summary

Congenital obstructive megaureter is a urinary malformation affecting the ureterovesical junction and causing obstruction to the flow of urine. It is the second most common cause of hydronephrosis. This malformation affects four times more boys than girls and is bilateral in 25% of cases. It is also associated with contralateral renal dysplasia in 15% of cases. The obstruction is linked to aperistalsis and hypertrophy of the circular muscle bundles and increased collagen 1 level. This malformation is accessible to antenatal screening from the second trimester. It falls within the scope of CAKUT and requires regular monitoring. Indeed, this uropathy can cause repeated pyelonephritis, kidney scarring and affected kidney function.

Conditions

Timeline

Start date
2020-09-02
Primary completion
2022-03-02
Completion
2022-03-31
First posted
2022-12-06
Last updated
2023-12-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05639283. Inclusion in this directory is not an endorsement.